Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens; Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

141

Participants

Timeline

Start Date

October 12, 2012

Primary Completion Date

May 3, 2017

Study Completion Date

May 8, 2017

Conditions

Cancer

Interventions

DRUG

Paclitaxel

DRUG

5-Fluorouracil (5FU)

DRUG

Carboplatin

DRUG

Leucovorin

DRUG

Irinotecan

DRUG

Paclitaxel

DRUG

BMS-906024

Trial Locations (5)

Local Institution, Brussels

Usc/Norris Comprehensive Cancer Center, Los Angeles

Local Institution, Edmonton

Local Institution, Toronto

Local Institution, Ottawa